Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression

Breast Cancer Research and Treatment

Volumn 130, Issue 1, 2011, Pages 307-317

  Fu, Peifen ^a,b   Ibusuki, Mutsuko ^a   Yamamoto, Yutaka ^a   Hayashi, Mitsuhiro ^a   Murakami, Keiichi ^a   Zheng, Shusen ^b   Iwase, Hirotaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; Insulin like growth factor 1 receptor; Prognosis

Indexed keywords

ANTHRACYCLINE; ANTIESTROGEN; AROMATASE INHIBITOR; CAPECITABINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; KI 67 ANTIGEN; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; NAVELBINE; SOMATOMEDIN C RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CANCER FREE SURVIVAL; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; GENE DOSAGE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR GENE; RELAPSE FREE SURVIVAL; SURVIVAL; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; PROTEIN BIOSYNTHESIS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; YOUNG ADULT;

EID: 82455167825     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1605-0     Document Type: Article

References (33)

1. Bradley LM, Gierthy JF, Pentecost BT (2008) Role of the insulinlike growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. J Steroid Biochem Mol Biol 109:185-196
2. Jones RA, Campbell CI, Wood GA, Petrik JJ, Moorehead RA (2009) Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene 28:2152-2162
3. Sachdev D, Yee D (2006) Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer. J Mammary Gland Biol Neoplasia 11:27-39 (Pubitemid 44309187)
4. Weroha SJ, Haluska P (2008) IGF-1 receptor inhibitors in clinical trials-early lessons. J Mammary Gland Biol Neoplasia 13:471-483
5. Chakraborty AK, Welsh A, Digiovanna MP (2010) Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines. Breast Cancer Res Treat 120:327-335
6. Samani AA, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47 (Pubitemid 46220849)
7. Shin A, Ren Z, Shu XO, Cai Q, Gao YT, Zheng W (2007) Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival. Breast Cancer Res Treat 105:55-61 (Pubitemid 47282744)
8. Maki RG (2010) Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 28:4985-4995
9. Lee AV, Hilsenbeck SG, Yee D (1998) IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat 47:295-302 (Pubitemid 28059824)
10. Hartog H, Horlings HM, van der Vegt B, et al (2010) Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma. Breast Cancer Res Treat. doi:10.1007/s10549-010-1256-6
11. Fagan DH, Yee D (2008) Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13:423-429
12. Jin Q, Esteva FJ (2008) Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer. J Mammary Gland Biol Neoplasia 13:485-498
13. Hopkins A, Crowe PJ, Yang JL (2010) Effect of type 1 insulinlike growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved. J Cancer Res Clin Oncol 136:639-650
14. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:3357-3365 (Pubitemid 46606270)
15. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569-1583 (Pubitemid 41511089)
16. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133-1144 (Pubitemid 47244357)
17. Yamamoto Y, Ibusuki M, Okumura Y et al (2008) Hypoxiainducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 110:465-475 (Pubitemid 351962589)
18. Hammond M E H, Hayes DF, Dowsett M et al (2010) American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795
19. Hastings PJ, Lupski JR, Rosenberg SM, Ira G (2009) Mechanisms of change in gene copy number. Nat Rev Genet 10:551-564
20. Fanciulli M, Petretto E, Aitman TJ (2010) Gene copy number variation and common human disease. Clin Genet 77:201-213
21. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182 (Pubitemid 17231334)
22. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M (1988) Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 48:161-164 (Pubitemid 18030345)
23. Rummukainen JK, Salminen T, Lundin J, Kytola S, Joensuu H, Isola JJ (2001) Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array. Mod Pathol 14:1030-1035 (Pubitemid 32976792)
24. Hui R, Campbell DH, Lee CS et al (1997) EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 15:1617-1623 (Pubitemid 27464656)
25. Holst F, Stahl PR, Ruiz C et al (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39:655-660 (Pubitemid 46676104)
26. Dziadziuszko R, Merrick DT, Witta SE et al (2010) Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol 28:2174-2180
27. Adéläide J, Finetti P, Bekhouche I et al (2007) Integrated profiling of basal and luminal breast cancers. Cancer Res 67:11565-11575
28. Berns E M J J, Klijn J G M, Van Staveren IL, Portengen H, Foekens JA (1992) Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors. Cancer Res 52:1036-1039
29. Hodak E, Gottlieb AB, Anzilotti M, Krueger JG (1996) The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J Invest Dermatol 106:554-570
30. Köstler WJ, Hudelist G, Rabitsch W et al (2005) Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer. J Cancer Res Clin 132:9-18 (Pubitemid 41712801)
31. Peiró G, Benlloch S, Sánchez-Tejada L et al (2008) Low activation of insulin-like growth factor 1-receptor (IGF1R) is associated with local recurrence in early breast carcinoma. Breast Cancer Res Treat 117:433-441
32. Werner H, Bruchim I (2009) The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 115:58-71
33. Jones RA, Moorehead RA (2008) The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia 13:407-413